Prot# 511.84: A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams to 100 Milligrams Daily in Women with Hypoactive Sexual Desire Disorder

Project: Research project

Project Details

StatusFinished
Effective start/end date7/18/077/18/10

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (511.84)